Literature DB >> 14757290

Clustering of components of the metabolic syndrome and risk for development of type 2 diabetes in Japanese male office workers.

Noriyuki Nakanishi1, Kazue Nishina, Mitsuharu Okamoto, Hiroshi Yoshida, Yoshio Matsuo, Kenji Suzuki, Kozo Tatara.   

Abstract

To investigate the effects of the clustering of components of the metabolic syndrome (MS) on development of diabetes, we examined 3298 Japanese male office workers aged 35-59 years who did not have type 2 diabetes (a fasting plasma glucose level of > or =7.0 mmol/l or receipt of hypoglycemic medication) or a history of cardiovascular disease. Fasting plasma glucose levels were measured at periodic annual health examinations from May 1994 through May 2001. After adjustment for potential risk factors for diabetes, the multivariate-adjusted relative risk of type 2 diabetes compared with the subjects without components of the MS was 1.58 (95% CI: 1.08-2.32), 2.48 (95% CI: 1.69-3.63), 3.10 (95% CI: 2.05-4.68), and 5.22 (95% CI: 3.49-7.83) (P-value for trend <0.001) for those with 1, 2, 3, and > or =4 components, respectively. Even after the subjects were stratified according to fasting plasma glucose level, the clustering of components of the MS was associated with an increased risk of type 2 diabetes for subjects in all three categories of low-normal fasting glucose (a fasting plasma glucose level of <5.1 mmol/l), high-normal fasting glucose (a fasting plasma glucose level of 5.0-6.0 mmol/l), and impaired fasting glucose (a fasting plasma glucose level of 6.1-6.9 mmol/l). These results indicate that clustering of components of the MS associated with diabetes precedes an increase in the risk of type 2 diabetes in Japanese men.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14757290     DOI: 10.1016/j.diabres.2003.08.007

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  5 in total

Review 1.  The metabolic syndrome in the asian population.

Authors:  Hiromi Rakugi; Toshio Ogihara
Journal:  Curr Hypertens Rep       Date:  2005-04       Impact factor: 5.369

2.  Uric acid is not associated with decline in renal function or time to renal replacement therapy initiation in a referred cohort of patients with Stage III, IV and V chronic kidney disease.

Authors:  Hakan Nacak; Merel van Diepen; Abdul R Qureshi; Juan J Carrero; Theo Stijnen; Friedo W Dekker; Marie Evans
Journal:  Nephrol Dial Transplant       Date:  2015-07-16       Impact factor: 5.992

3.  Stepwise positive association between APOA5 minor allele frequencies and increasing plasma triglyceride quartiles in random patients with hypertriglyceridemia of unclarified origin.

Authors:  Ferenc Hadarits; Péter Kisfali; Márton Mohás; Anita Maász; Katalin Sümegi; Melinda Szabó; Katalin Hetyésy; Andrea Valasek; Ingrid Janicsek; István Wittmann; Béla Melegh
Journal:  Pathol Oncol Res       Date:  2010-05-19       Impact factor: 3.201

4.  Risk and population attributable fraction of metabolic syndrome and impaired fasting glucose for the incidence of type 2 diabetes mellitus among middle-aged Japanese individuals: Aichi Worker's Cohort Study.

Authors:  Kayo Kaneko; Hiroshi Yatsuya; Yuanying Li; Mayu Uemura; Chifa Chiang; Yoshihisa Hirakawa; Atsuhiko Ota; Koji Tamakoshi; Atsuko Aoyama
Journal:  J Diabetes Investig       Date:  2020-03-03       Impact factor: 4.232

5.  Relationship between Biological Markers, Metabolic Components, Lifestyles, and Impaired Fasting Glucose in Male Workers.

Authors:  Tomoyuki Kawada
Journal:  Diabetes Metab J       Date:  2015-10-22       Impact factor: 5.376

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.